scispace - formally typeset
E

Erwin G. Van Meir

Researcher at University of Alabama at Birmingham

Publications -  202
Citations -  39049

Erwin G. Van Meir is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Glioma & Cancer. The author has an hindex of 75, co-authored 183 publications receiving 32866 citations. Previous affiliations of Erwin G. Van Meir include Emory University & University Hospital of Lausanne.

Papers
More filters
Journal ArticleDOI

Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity.

TL;DR: It is shown that overexpression of EGfr or EGFRvIII in human glioma cells causes increased basal TF expression and that stimulation of EGFR by its ligand, EGF, leads to a marked dose-dependent up-regulation of TF, which led to accelerated plasma coagulation in vitro.
Journal ArticleDOI

Noscapine Crosses the Blood-Brain Barrier and Inhibits Glioblastoma Growth

TL;DR: It is shown that noscapine inhibits the proliferation of rat C6 glioma cells in vitro and effectively crosses the blood-brain barrier at rates similar to the ones found for agents such as morphine and [Met]enkephalin that have potent central nervous system activity.
Journal ArticleDOI

Hypoxia inducible factor-1: a novel target for cancer therapy.

TL;DR: This work highlights some of the recently developed small-molecule inhibitors of HIF-1 function, which disrupt the H IF-1 signaling pathway through a variety of mechanisms, including the inhibition of Hif-1&agr; protein synthesis, stabilization, nuclear translocation and HIF1 transactivation of target genes.
Journal Article

The PTEN Lipid Phosphatase Domain Is Not Required to Inhibit Invasion of Glioma Cells

TL;DR: It is concluded that phosphatase-independent domains of PTEN markedly reduced the invasive potential of glioma cells, defining a structural role for PTEN that regulates cell motility distinct of the PKB/Akt pathway.
Journal ArticleDOI

Brain cancer propagating cells: biology, genetics and targeted therapies

TL;DR: Treatments that include specific targeting of BCPCs might potentially be more effective at treating the entire tumor mass, translating to improved patient survival and quality of life.